Institute for Translational Neuroscience
The Institute for Translational Neuroscience's greatest strength is bringing together different groups under one common goal: to advance neuroscience research at the University of Minnesota.
The Institute for Translational Neuroscience (ITN) was established in 2007 as a University-wide presidential initiative to promote the transfer of discoveries in the basic neurosciences to clinical practice. The institute is charged to enhance basic science discovery with new knowledge leading to subsequent clinical trials and establishment of new therapeutic principles or tools. Click here to learn more about the history of our Institute.
The faculty at the Institute for Translational Neuroscience would like to extend their congratulations to Dr. Michael Lee and his lab for their recent accomplishments. Dr. Lee, a neuroscience researcher and ITN Scholar, was awarded over $2.2 million from NINDS for his R01 grant titled "Pathological role of c-Abl in alpha-synucleinoapathy". One of the main goals of his proposal is to understand how anti—Cancer therapy, c-Abl inhibitors, can be used to treat Parkinson's Disease by activating cellular processes that remove toxic build up in cells.
In addition to this grant, Dr. Lee, Dr. Dezhi Liao, and Dr. Eugenia Trushina from the Mayo Clinic, were awarded a 2 year grant titled "Molecular Mechanism of Novel Small Molecule Therapeutics for Alzheimer's Disease" from Minnesota Partnership for Biotechnology and Medical Genomics. The total award amount was over $1 million.
These honors have extended to other members of Dr. Lee’s laboratory as well. Dr. Christopher Gallardo, a Pharmacology graduate student, was recently awarded a “Functional Proteomics of Aging (FPA)” Fellowship for two years. This fellowship is a NIA funded training grant headed by Drs. LaDora Thompson and Deborah Ferrington. Dr. Gallardo is studying the role of tau in amyloid dependent neurodegeneration in mouse models of Alzheimer's disease.
Please help us congratulate the great work being conducted by our Institute's researchers!
Our main goal is to attract and recruit top scientists to shape discoveries that will lead to tomorrow's cures. The institute exemplifies how different disciplines, departments, and centers can work together in partnership to evolve neurological disease research at the University of Minnesota. We have built a community that encourages learning, education, innovation, and discovery all of which are more successful in a team oriented environment.
These world-class centers embrace and advance the institute's mission:
- Center for Magnetic Resonance Research
- Center for Neuroengineering
- Center for Neurodegenerative Disease
- N. Bud Grossman Center for Memory Research and Care